Chiang Mai University researchers induced human amniotic-fluid mesenchymal stem cells to adopt neuron-like morphology and upregulate nestin, β-III-tubulin and tyrosine hydroxylase, with corresponding immunofluorescent proteins. This shows in-vitro differentiation potential, not functional dopaminergic neurons, safety or Parkinson's disease therapy.
Key findings
- Starting cells met reported MSC criteria and proliferated. Induction produced neuron-like morphology, significantly higher nestin, β-III-tubulin and tyrosine-hydroxylase expression, and related immunofluorescent proteins. The abstract gives no effect sizes, marker-positive proportions, electrophysiology or dopamine secretion.
Why this matters globally
Amniotic-fluid cells may offer a regenerative source if reproducibly converted into safe, functional neurons. Clinical translation requires rigorous manufacturing and preclinical standards.
Thai researcher contribution
Chiang Mai University and its tissue-engineering/stem-cell centre carried the work from MSC confirmation through induction and neural-marker assessment.
Limitations to consider
Donor count, biological replicates, controls and conversion efficiency are unclear. TH expression does not prove dopamine production or mature phenotype. There was no electrophysiology, single-cell profile, tumourigenicity, genomic stability, animal model or long-term survival, and donor variability may be substantial.
Verify the original sources
Anatomy & Cell BiologyRead the original article↗DOI: 10.5115/acb.25.361